EndoForce Connector Study for Dialysis Graft Access
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is testing a new connector system (EndoForce) used during dialysis graft placement in people with kidney failure. Researchers want to make sure it works safely and effectively in real-world use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have end-stage renal disease (kidney failure) and need a special plastic tube (graft) placed in your arm to connect you to a dialysis machine.
- Your doctor can place the graft in your upper arm.
- You (or your legal guardian) understand what the study involves, agree to follow the dialysis schedule and study visits, and sign a consent form.
- You are not pregnant, and you are not already in another dialysis or blood vessel study (unless the study sponsor says it is okay).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new graft (a tube) that helps people with kidney failure get hemodialysis (a treatment that cleans the blood). The graft is placed in the arm to create a reliable access point for dialysis, and the trial will check how safe and effective it is.
This study tests whether an “AV graft” implant works safely and well for people with end-stage kidney disease who need hemodialysis. It may help your dialysis access last and work better, compared with current expectations for AV grafts.
This trial tests a new device called the Velocity pAVF System that creates a connection between a vein and artery in your arm for hemodialysis. If you need dialysis now or within the next 6 months, this could be a new option for you.
This trial tests a new type of dialysis access graft (called aXess-E) for people with kidney failure who need a graft in their arm. It aims to see if the graft works well for long-term dialysis.
This trial tests a new graft (artificial blood vessel) placed in your upper arm to help you receive kidney dialysis. The graft connects an artery to a vein, creating a reliable access point for dialysis needles.
This study monitors how well the BD WavelinQ endoAVF device works after routine clinical use. It may help people who need a dialysis access fistula by sharing real-world safety and performance data.
Hear when a new End Stage Renal Disease (ESRD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.